scholarly journals Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary

2020 ◽  
Vol 38 (4) ◽  
pp. 324-327
Author(s):  
John Anderson ◽  
Scott Urquhart ◽  
Geralyn Spollett ◽  
Paresh Dandona
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin ◽  
Executive Summary ◽  
Increased Risk

scholarly journals Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk

2021 ◽  
Author(s):  
John Anderson ◽  
Geralyn R. Spollett ◽  
Paresh Dandona ◽  
Scott Urquhart
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin ◽  
Conflicts Of Interest ◽  
International Committee ◽  
Executive Summary ◽  
Roles And Responsibilities ◽  
Good Publication ◽  
Increased Risk ◽  
Short Video

<p>Many people with type 2 diabetes are treated with insulin with the goal of achieving a specific A1C target. In this short video series, an expert panel moderated by John Anderson, MD, discusses approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those patients most at risk (e.g., those with renal impairment and older adults), with a focus on reaching A1C goals while mitigating the risk for hypoglycemia.</p><p>The panel discusses how considerations for the management of hypoglycemia are important in these patients. When used appropriately, the risk of hypoglycemia with basal insulin analogs can be reduced while still achieving individualized glycemic goals.</p><p>The videos can be viewed in their entirety here, and an executive summary of the panel’s recommendations is available on the <em>Clinical Diabetes</em> website at <a href="https://doi.org/10.2337/cd20-0035">https://doi.org/10.2337/cd20-0035</a>.</p><p>This peer-reviewed publication was developed in adherence with <a href="http://annals.org/aim/fullarticle/2424869/good-publication-practice-communicating-company-sponsored-medical-research-gpp3" target="_blank">Good Publication Practice (GPP3)</a> guidelines. All authors meet the <a href="http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html" target="_blank">International Committee of Medical Journal Editors (ICMJE)</a> criteria for authorship and have disclosed all potential <a href="https://clinical.diabetesjournals.org/content/basal-insulin-videos#DIS">conflicts of interest</a>.</p>

scholarly journals Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk

2021 ◽  
Author(s):  
John Anderson ◽  
Geralyn R. Spollett ◽  
Paresh Dandona ◽  
Scott Urquhart
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin ◽  
Conflicts Of Interest ◽  
International Committee ◽  
Executive Summary ◽  
Roles And Responsibilities ◽  
Good Publication ◽  
Increased Risk ◽  
Short Video

<p>Many people with type 2 diabetes are treated with insulin with the goal of achieving a specific A1C target. In this short video series, an expert panel moderated by John Anderson, MD, discusses approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those patients most at risk (e.g., those with renal impairment and older adults), with a focus on reaching A1C goals while mitigating the risk for hypoglycemia.</p><p>The panel discusses how considerations for the management of hypoglycemia are important in these patients. When used appropriately, the risk of hypoglycemia with basal insulin analogs can be reduced while still achieving individualized glycemic goals.</p><p>The videos can be viewed in their entirety here, and an executive summary of the panel’s recommendations is available on the <em>Clinical Diabetes</em> website at <a href="https://doi.org/10.2337/cd20-0035">https://doi.org/10.2337/cd20-0035</a>.</p><p>This peer-reviewed publication was developed in adherence with <a href="http://annals.org/aim/fullarticle/2424869/good-publication-practice-communicating-company-sponsored-medical-research-gpp3" target="_blank">Good Publication Practice (GPP3)</a> guidelines. All authors meet the <a href="http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html" target="_blank">International Committee of Medical Journal Editors (ICMJE)</a> criteria for authorship and have disclosed all potential <a href="https://clinical.diabetesjournals.org/content/basal-insulin-videos#DIS">conflicts of interest</a>.</p>

Reasons for different patterns of basal insulin persistence after initiation among people with type 2 diabetes (T2D)

2017 ◽  
Vol 12 (S 01) ◽  
pp. S1-S84
Author(s):  
M Peyrot ◽  
J Ivanova ◽  
C Zao ◽  
L Schmerold ◽  
S King ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Basal Insulin

Switching to Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control and Reduces Nocturnal Hypoglycemia in Patients (Pts) with Type 2 Diabetes (T2DM) on Basal Insulin Supported Oral Therapy (BOT)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1020-P ◽  
Author(s):  
JOCHEN SEUFERT ◽  
ANDREAS FRITSCHE ◽  
HELMUT ANDERTEN ◽  
KATRIN PEGELOW ◽  
STEFAN PSCHERER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Glargine ◽  
Basal Insulin ◽  
Oral Therapy ◽  
Nocturnal Hypoglycemia

11-LB: Nonsevere Hypoglycemia Predicts Increased Risk of Subsequent Severe Events in Patients with Type 2 Diabetes

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 11-LB
Author(s):  
SIMON R. HELLER ◽  
ELISE HACHMANN-NIELSEN ◽  
KAJSA KVIST
Keyword(s):  
Type 2 Diabetes ◽  
Increased Risk
Sign in / Sign up

Export Citation Format

Share Document